366 - If the product is in a therapeutic area where we cannot use IMS data because of market definitions, can we use patient chart study or any other form of study to show our performance in the market. Are there specific guidelines on sample or methodology?
This sounds like a case I have not encountered before. Please call me at the office so we can discuss as I'll need more background information. Thanks, Patrick.
